Abstract
Background: Cardiac troponins are very sensitive and specific indicators of myocardial damage; however, they are sometimes found to be increased in patients with end‐stage renal disease (ESRD).
Hypothesis: The aim of this study was to determine cardiac troponin I (cTpI) and creatine kinase myocardial isoform (CK‐MB) levels and to assess their diagnostic and prognostic importance before and after renal transplantation.
Methods: Thirty‐four patients with ESRD (mean age 31.8 ± 8.6 years, 11 women) were enrolled. Serum levels of cTpI and CK‐MB were measured pre‐ and postoperatively on Days 1, 7, and 30. Patients were followed up for cardiac events, and possible myocardial damage was investigated by exercise thalli‐um‐201‐labeled myocardial perfusion scintigraphy. Mean cTpI levels were 0.24 ± 0.11 ng/ml (preoperative), and 0.34 ± 0.27 ng/ml (Day 1), 0.26 ± 0.11 ng/ml (Day 7), and 0.28 ± 0.30 ng/ml (Day 30).
Results: Compared with preoperative levels, cTpI was increased in 16 (47%), decreased in 6 (17.6%), and did not change in 12 (35.4%) patients. However, the increase did not exceed the myocardial infarction reference level of 2.3 ng/ml in any patient. Mean CK‐MB levels were 12.6 8.7U/l (preoperative), and 16.8 ± 9.2U/l (Day 1), 16.3 ± 8.1U/l (Day 7), and 13.3 ± 6.6U/l (Day 30). Creatine kinase‐MB was increased to above normal levels of 24 U/l in 13 (38.2%) patients on postoperative Days 1 or 7, and decreased to normal at the end of Month 1. No cardiac events occurred, and there was no abnormality in any patient on thallium scintigraphy.
Conclusion: There was no significant difference in the levels of cTpI in patients with ESRD without cardiac events before and after renal transplantation (p > 0.05). Our findings show that cTpI has very high sensitivity and specificity for detecting cardiac damage in patients with ESRD after renal transplantation.
Keywords: cardiac troponin I, creatine kinase‐MB, end‐stage, renal disease, renal transplantation
Full Text
The Full Text of this article is available as a PDF (28.8 KB).
References
- 1. Katus HA, Scheffold T, Remppis A, Zehelein J: Proteins of the troponin complex. Lab Med 1992; 23: 311–317 [Google Scholar]
- 2. Hamm CW: New serum markers for acute myocardial infarction. N Engl J Med 1994; 331: 607–608 [DOI] [PubMed] [Google Scholar]
- 3. Adams JE, Bodor GS, Davila‐Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88: 101–106 [DOI] [PubMed] [Google Scholar]
- 4. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W: Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902–912 [DOI] [PubMed] [Google Scholar]
- 5. Rottbauer W, Greten T, Muller‐Bardorff M, Remppis A, Zehelein J, Grunig E, Katus HA: Troponin T: A diagnostic marker for myocardial infarction and minor cardiac cell damage. Eur Heart J 1996; 17 219: (suppl F): 3–8 [DOI] [PubMed] [Google Scholar]
- 6. Croltoru M, Taegtmeyer H: Spurious rises in troponin T in end‐stage renal disease (letter). Lancet 1995; 346: 974 [DOI] [PubMed] [Google Scholar]
- 7. Li D, Keffer J, Corry K, Vazquez M, Jialal I: Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 1995; 28: 474–477 [DOI] [PubMed] [Google Scholar]
- 8. Collinson PO, Stubbs PJ, Rosalki SB: Cardiac troponin T in renal disease. Clin Chem 1995; 41: 1671–1673 [PubMed] [Google Scholar]
- 9. Haller C, Zehelein J, Remppis A, Muller‐Bardorff M, Katus HA: Cardiac troponin T in patients with end‐stage renal disease: Absence of expression in frontal skeletal muscle. Clin Chem 1998; 44: 930–938 [PubMed] [Google Scholar]
- 10. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW: Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43: 976–982 [PubMed] [Google Scholar]
- 11. Apple FS, Sharkey SW, Hoeft B, Skeate R, Voss E, Dahlmeier BA, Preese LM: Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1‐year outcomes analysis. Am J Kidney Dis 1997; 29: 399–403 [DOI] [PubMed] [Google Scholar]
- 12. Katus HA, Haller C, Muller‐Bardoff M, Scheffold T, Remppis A: Cardiac troponin T in end‐stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 1995; 41: 1201–1202 [PubMed] [Google Scholar]
- 13. Hafner G, Thome‐Kromen B, Schaube J, Kupferwasser I, Ehrenthal W, Cummins P, Prellwitz W, Michel G: Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40: 1790–1791 [PubMed] [Google Scholar]
- 14. United States Renal Data System : Patient mortality and survival. Am J Kidney Dis 1997; 30: S86–106 [PubMed] [Google Scholar]
- 15. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP: Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: 1136–1142 [DOI] [PubMed] [Google Scholar]
- 16. Gradaus F, Ivens K, Peters AJ, Heering P, Schoebel FC, Grabensee B, Strauer BE: Angiographic progression of coronary artery disease in patients with end‐stage renal disease. Nephrol Dial Transplant 2001; 16: 1198–1202 [DOI] [PubMed] [Google Scholar]
- 17. Keoman JP, Leunissen KM: Cardiovascular aspects in renal disease. Curr Opin Nephrol Hypertens 1993; 2: 791–797 [DOI] [PubMed] [Google Scholar]
- 18. Linder A, Charra B, Sherrard DJ, Sribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701 [DOI] [PubMed] [Google Scholar]
- 19. Bennett AE, Bertholf RL: Discordant results of CK‐MB and troponin I: A review of 14 cases. Ann Clin Lab Sci 2000; 30: 167–173 [PubMed] [Google Scholar]
- 20. Medeiros LJ, Schotte D, Gerson B: Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients. Am J Clin Pathol 1987; 87: 103–108 [DOI] [PubMed] [Google Scholar]
- 21. Green TR, Golpher TA, Swenson RD, Pulliam JP, Morris CD: Diagnostic value of creatine kinase and creatine kinase MB isoenzyme in chronic hemodialysis patients: A longitudinal study. Clin Nephrol 1986; 25: 22–27 [PubMed] [Google Scholar]
- 22. Ma KW, Brown DC, Steele BW, From AHL: Serum creatine kinase MB isoenzyme activity in long‐term hemodialysis patients. Arch Intern Med 1981; 141: 164–166 [PubMed] [Google Scholar]
- 23. Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel A: A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veterans Hospital: A pilot study. J Am Coll Cardiol 1999; 34: 448–454 [DOI] [PubMed] [Google Scholar]
- 24. Musso P, Cox I, Vidano E, Zambon D, Panteghini M: Cardiac troponin elevations in chronic renal failure: Prevalence and clinical significance. Clin Biochem 1999; 32: 125–130 [DOI] [PubMed] [Google Scholar]
- 25. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE: Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: A case matched study. J Am Coll Cardiol 1999; 33: 471–478 [DOI] [PubMed] [Google Scholar]
- 26. Wu AHB, Feng YJ, Roper L, Herbert K, Schweizer R: Cardiac troponins T and I before and after renal transplantation. Clin Chem 1999; 43: 411A–412A [PubMed] [Google Scholar]